Mufg Americas Holdings Position in Goldman Sachs Group (GS) Has Lowered by $1.64 Million as Stock Price Declined; Beaconlight Capital Decreased Its Bio Rad Labs (BIO) Holding by $3.88 Million

June 17, 2018 - By Marie Mckinney

The Goldman Sachs Group, Inc. (NYSE:GS) Logo

Mufg Americas Holdings Corp decreased its stake in Goldman Sachs Group Inc (GS) by 13.5% based on its latest 2018Q1 regulatory filing with the SEC. Mufg Americas Holdings Corp sold 6,524 shares as the company’s stock declined 13.36% with the market. The institutional investor held 41,801 shares of the finance company at the end of 2018Q1, valued at $10.53M, down from 48,325 at the end of the previous reported quarter. Mufg Americas Holdings Corp who had been investing in Goldman Sachs Group Inc for a number of months, seems to be less bullish one the $87.60B market cap company. The stock decreased 0.74% or $1.73 during the last trading session, reaching $231.92. About 4.74 million shares traded or 51.45% up from the average. The Goldman Sachs Group, Inc. (NYSE:GS) has risen 5.64% since June 17, 2017 and is uptrending. It has underperformed by 6.93% the S&P500. Some Historical GS News: 17/04/2018 – US The Retail Economist/Goldman Sachs Chain Store Sales +0.3% In Apr 14 Wk; 17/04/2018 – GOLDMAN CFO: NO CHANGES TO GROWTH TARGETS ON MARCUS; 07/03/2018 – Yahoo! UK: Exclusive – Goldman puts London staff on notice for German move by June; 24/05/2018 – GSO IS SAID TO BE BUYER OF GOLDMAN POSITION IN HOVNANIAN CDS; 09/03/2018 – Looking at Goldman’s history of executives, it’s also possible Solomon and Schwartz could lead the bank together after Blankfein leaves, said CFRA bank analyst Ken Leon; 15/03/2018 – EU watchdog criticises Brussels handling of Barroso’s Goldman move; 17/04/2018 – Goldman Sachs Raises Dividend to 80c Vs. 75c; 21/05/2018 – IHS MARKIT TO BUY IPREO FROM BLACKSTONE & GOLDMAN SACHS MERCHAN; 12/03/2018 – CNBC Now: BREAKING: Harvey Schwartz, Goldman Sachs president and co-chief operating officer, has decided to retire effective…; 13/04/2018 – Goldman banker to take over […]

Ed Bosek decreased its stake in Bio Rad Labs Inc (BIO) by 29.27% based on its latest 2018Q1 regulatory filing with the SEC. Beaconlight Capital Llc sold 15,515 shares as the company’s stock rose 11.67% while stock markets declined. The hedge fund run by Ed Bosek held 37,490 shares of the capital goods company at the end of 2018Q1, valued at $9.38M, down from 53,005 at the end of the previous reported quarter. Beaconlight Capital Llc who had been investing in Bio Rad Labs Inc for a number of months, seems to be less bullish one the $9.03 billion market cap company. The stock increased 0.06% or $0.18 during the last trading session, reaching $303.88. About 190,378 shares traded or 28.09% up from the average. Bio-Rad Laboratories, Inc. (NYSE:BIO) has risen 30.04% since June 17, 2017 and is uptrending. It has outperformed by 17.47% the S&P500. Some Historical BIO News: 08/05/2018 – BIO-RAD SEES FY REV. CHANGE EX-FX +3.5% TO +4%; 16/03/2018 – Bio-Rad Says it Won’t File Annual Report by Extended Deadline; 08/05/2018 – Bio-Rad Laboratories 1Q Adj EPS $1.17; 22/03/2018 – Bio-Rad Laboratories, Inc. Receives Expected NYSE Notice Regarding Late Form 10-K Filing; 22/04/2018 – DJ Bio-Rad Laboratories Inc Class B, Inst Holders, 1Q 2018 (BIO.B); 16/03/2018 – Bio-Rad Labs: Internal Control Over Financial Reporting Not Effective as of Dec. 31; 08/05/2018 – BIO-RAD 1Q EPS $21.77, EST. $1.040; 16/03/2018 – Bio-Rad Labs Delay Prompted by Conversion to New ERP System, Business Structure for European Operations; 16/04/2018 – Bio-Rad Closes Above 50-Day Moving Average: Technicals; 22/03/2018 – Bio-Rad Laboratories Receives Expected NYSE Notice Regarding Late Form 10-K Filing

More notable recent The Goldman Sachs Group, Inc. (NYSE:GS) news were published by: Seekingalpha.com which released: “Goldman Sachs Asset Management starts ETF based on good corporate behavior” on June 12, 2018, also Globenewswire.com with their article: “Analysis: Positioning to Benefit within Vector Group, The Goldman Sachs Group, LivaNova, IRSA Inversiones Y …” published on June 15, 2018, Seekingalpha.com published: “Goldman Sachs: Runway For Growth” on May 23, 2018. More interesting news about The Goldman Sachs Group, Inc. (NYSE:GS) were released by: Themiddlemarket.com and their article: “M&A daily wrap: Oak Hill, Harvest Partners, Cressey, VetCor, GI Partners, dealmaker’s guide to summer reading” published on June 15, 2018 as well as Livetradingnews.com‘s news article titled: “The Goldman Sachs Group, Inc. (NYSE:GS) Stock Oversold” with publication date: May 21, 2018.

Since January 18, 2018, it had 0 buys, and 8 insider sales for $22.92 million activity. 4,400 shares were sold by ROGERS JOHN F.W., worth $1.17M. $2.70M worth of The Goldman Sachs Group, Inc. (NYSE:GS) was sold by SALAME PABLO J. The insider SOLOMON DAVID M sold 3,497 shares worth $854,665. 11,829 The Goldman Sachs Group, Inc. (NYSE:GS) shares with value of $3.07M were sold by CHAVEZ R. MARTIN. Shares for $1.78 million were sold by LEE BRIAN J.

Analysts await The Goldman Sachs Group, Inc. (NYSE:GS) to report earnings on July, 17. They expect $4.72 EPS, up 19.49% or $0.77 from last year’s $3.95 per share. GS’s profit will be $1.78B for 12.28 P/E if the $4.72 EPS becomes a reality. After $6.95 actual EPS reported by The Goldman Sachs Group, Inc. for the previous quarter, Wall Street now forecasts -32.09% negative EPS growth.

Mufg Americas Holdings Corp, which manages about $3.17B US Long portfolio, upped its stake in Crown Castle Intl Corp New (NYSE:CCI) by 4,729 shares to 4,893 shares, valued at $536,000 in 2018Q1, according to the filing. It also increased its holding in Vanguard Tax Managed Intl Fd (VEA) by 237,257 shares in the quarter, for a total of 1.68 million shares, and has risen its stake in Mondelez Intl Inc (NASDAQ:MDLZ).

Investors sentiment increased to 1.16 in 2018 Q1. Its up 0.17, from 0.99 in 2017Q4. It improved, as 61 investors sold GS shares while 357 reduced holdings. 140 funds opened positions while 345 raised stakes. 266.01 million shares or 1.06% less from 268.85 million shares in 2017Q4 were reported. Ltd Ca reported 5,559 shares. Conning Incorporated has 0.13% invested in The Goldman Sachs Group, Inc. (NYSE:GS). 12 are owned by Polaris Greystone Gp Limited Liability. Natl Bank Of Nova Scotia stated it has 0.09% in The Goldman Sachs Group, Inc. (NYSE:GS). Proshare Advsrs Lc stated it has 0.58% in The Goldman Sachs Group, Inc. (NYSE:GS). New Jersey Better Educational Savings holds 0.42% or 1,500 shares in its portfolio. Mitsubishi Ufj And Corp holds 753,491 shares. State Of Tennessee Treasury Department has invested 0.4% in The Goldman Sachs Group, Inc. (NYSE:GS). 12,584 were accumulated by Exchange Capital Mngmt. Iat Reinsurance invested in 111,500 shares. Everence Management holds 0.37% or 6,567 shares in its portfolio. Mariner Wealth Advisors owns 814 shares or 0.01% of their US portfolio. Neuberger Berman Gp Limited Liability reported 0.67% stake. Winfield Assoc Inc has 3,700 shares. Horrell Mngmt holds 0.06% or 450 shares.

Among 32 analysts covering Goldman Sachs Group Inc. (NYSE:GS), 14 have Buy rating, 1 Sell and 17 Hold. Therefore 44% are positive. Goldman Sachs Group Inc. had 109 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Hold” rating given on Wednesday, August 12 by Deutsche Bank. The rating was upgraded by Deutsche Bank on Wednesday, November 30 to “Buy”. On Wednesday, August 23 the stock rating was maintained by BMO Capital Markets with “Hold”. The firm earned “Neutral” rating on Wednesday, December 21 by Atlantic Securities. The stock of The Goldman Sachs Group, Inc. (NYSE:GS) has “Hold” rating given on Tuesday, January 9 by Keefe Bruyette & Woods. On Monday, October 17 the stock rating was upgraded by Rafferty to “Buy”. The stock has “Neutral” rating by Citigroup on Tuesday, November 8. On Wednesday, April 18 the stock rating was maintained by Buckingham Research with “Neutral”. Citigroup maintained The Goldman Sachs Group, Inc. (NYSE:GS) rating on Monday, October 9. Citigroup has “Neutral” rating and $250 target. The firm earned “Buy” rating on Monday, April 23 by Oppenheimer.

Investors sentiment decreased to 1.03 in 2018 Q1. Its down 0.10, from 1.13 in 2017Q4. It is negative, as 18 investors sold BIO shares while 101 reduced holdings. 42 funds opened positions while 81 raised stakes. 18.53 million shares or 0.19% less from 18.57 million shares in 2017Q4 were reported. Cubist Systematic Strategies Limited Liability Co holds 467 shares. State Street has invested 0.01% in Bio-Rad Laboratories, Inc. (NYSE:BIO). Granahan Inv Mgmt Ma has 38,065 shares for 0.69% of their portfolio. 2,600 were reported by Grantham Mayo Van Otterloo & Co Limited Liability Co. Synovus Fincl, Georgia-based fund reported 1,674 shares. Morgan Stanley owns 0.01% invested in Bio-Rad Laboratories, Inc. (NYSE:BIO) for 92,871 shares. Financial Svcs has 52 shares for 0.01% of their portfolio. Clinton Grp holds 0.21% of its portfolio in Bio-Rad Laboratories, Inc. (NYSE:BIO) for 7,731 shares. Fort Washington Inv Advisors Oh, a Ohio-based fund reported 312,812 shares. 94,240 are owned by Sector Gamma As. 3,800 were reported by Old Mutual Invsts (Uk) Limited. Moreover, C M Bidwell & Assoc Ltd has 0.81% invested in Bio-Rad Laboratories, Inc. (NYSE:BIO) for 3,520 shares. 3,491 are held by Three Peaks Mngmt Limited Liability Corp. First Quadrant LP Ca, California-based fund reported 17,679 shares. Mutual Of America Cap Mgmt Limited Liability has 16,583 shares.

More recent Bio-Rad Laboratories, Inc. (NYSE:BIO) news were published by: Stockhouse.com which released: “Bio-Rad to Present at Jefferies 2018 Global Healthcare Conference on June 5” on May 31, 2018. Also Gurufocus.com published the news titled: “6 Stocks Beating the Market” on June 13, 2018. Gurufocus.com‘s news article titled: “Pioneer Makes Early Gains on Top Buys of 1st Quarter” with publication date: May 30, 2018 was also an interesting one.

Among 5 analysts covering Bio-Rad Laboratories (NYSE:BIO), 3 have Buy rating, 0 Sell and 2 Hold. Therefore 60% are positive. Bio-Rad Laboratories had 20 analyst reports since August 7, 2015 according to SRatingsIntel. The rating was maintained by Jefferies on Friday, April 28 with “Buy”. The company was maintained on Wednesday, September 27 by Jefferies. The stock of Bio-Rad Laboratories, Inc. (NYSE:BIO) earned “Hold” rating by C.L. King on Friday, February 16. The rating was maintained by Jefferies with “Buy” on Wednesday, September 7. On Wednesday, April 12 the stock rating was maintained by Jefferies with “Buy”. The firm has “Buy” rating by Jefferies given on Friday, October 20. As per Tuesday, March 20, the company rating was maintained by Wells Fargo. The firm has “Buy” rating given on Thursday, June 8 by Jefferies. The company was downgraded on Friday, February 16 by CL King. The stock has “Buy” rating by Deutsche Bank on Wednesday, June 28.

Beaconlight Capital Llc, which manages about $170.27 million and $266.66 million US Long portfolio, upped its stake in Simpson Manufacturing Co Inc (NYSE:SSD) by 72,900 shares to 303,945 shares, valued at $17.50 million in 2018Q1, according to the filing. It also increased its holding in Kinder Morgan Inc Del (NYSE:KMI) by 78,600 shares in the quarter, for a total of 333,800 shares, and has risen its stake in Ypf Sociedad Anonima (Call) (NYSE:YPF).

Bio-Rad Laboratories, Inc. (NYSE:BIO) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>